GW Pharmaceuticals PLC (NASDAQ:GWPH) stock surged some 10% during trading 6 June Friday on news the U.S. Food and Drug Administration granted Fast Track designation status to the British company’s product Epidiolex. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) net profit margin is -24.90% and weekly performance is 5.60%. On last trading day company shares ended up $71.99. Analysts mean target price for the company is $92.40. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) distance from 50-day simple moving average (SMA50) is 14.08%.
Omeros Corporation (NASDAQ:OMER) Director Thomas J. Cable sold 5,000 shares of Omeros stock on the open market in a transaction dated Monday, June 2nd. The stock was sold at an average price of $11.80, for a total value of $59,000.00. Following the completion of the sale, the director now directly owns 62,067 shares of the company’s stock, valued at approximately $732,391. Omeros Corporation (NASDAQ:OMER) shares advanced 8.37% in last trading session and ended the day on $13.33. OMER return on assets is -170.50%.Omeros Corporation (NASDAQ:OMER) quarterly performance is 2.30%.
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) will be presenting at the Goldman Sachs 35th Annual Global Healthcare Conference on June 10, 2014, at 4:00 p.m. PT (7:00 p.m. ET) in Palo Verdes, CA.
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) shares moved up 8.95% in last trading session and was closed at $10.83, while trading in range of $9.87 – $10.84. Infinity Pharmaceuticals Inc. (NASDAQ:INFI) year to date (YTD) performance is -21.58%.
Analogic Corporation (NASDAQ:ALOG), a Peabody maker of medical and security imaging technology, on 5 June, Thursday reported revenue for the third quarter of fiscal 2014 was $124 million, generally in line with what analysts had been expecting. Analogic Corporation (NASDAQ:ALOG) ended the last trading day at $73.20. Company weekly volatility is calculated as 2.56% and price to cash ratio as 8.18.Analogic Corporation (NASDAQ:ALOG) showed a positive weekly performance of 7.14%.
InspireMD Inc. (NASDAQ:NSPR) VP Eric L. Olson purchased 31,778 shares of the stock on the open market in a transaction dated Thursday, May 29th. The shares were purchased at an average cost of $2.55 per share, with a total value of $81,033.90. Following the completion of the transaction, the vice president now directly owns 31,778 shares of the company’s stock, valued at approximately $81,034. InspireMD Inc. (NYSEMKT:NSPR) weekly performance is 11.60%. On last trading day company shares ended up $2.79. Analysts mean target price for the company is $5.17. InspireMD Inc. (NYSEMKT:NSPR) distance from 50-day simple moving average (SMA50) is 9.51%.